Exabis Library
Welcome to the e-CCO Library!
P353: Pan-enteric capsule endoscopy enables assessment of mucosal healing after biologic treatment initiation in Crohn’s disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P353: Ulcerative Colitis in the IBSEN III study: Frequent use of biologics and low colectomy rates first year of disease.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P354 Objectively measured time spent sitting, standing upright, and stepping is associated with disease severity and faecal calprotectin in patients with ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P354: A prospective randomised study: 2 mg/kg/d of azathioprine is an appropriate dosage for Chinese patients with Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P354: Application of the clinical decision support tool to predict treatment outcomes in Crohn's Disease patients treated with vedolizumab subcutaneous formulation
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P354: Early treatment versus active surveillance after ileocolic resection in Crohn’s disease: a retrospective cohort study.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P354: Immunological response to vaccination against SARS-COV-2 infection in Inflammatory Bowel Disease patients under immunosuppressive therapy: should we prioritize an additional booster injection?
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P354: Perceived Quality of Care is associated to quality of life, work productivity and gender but not disease phenotype: a prospective study in a high-volume IBD centre
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P354: Refinement and confirmation of psychometric properties of the Inflammatory Bowel Disease Distress Scale (IBD-DS): A new tool to measure disease-specific distress
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P354: The effect of value based health care delivery for inflammatory bowel diseases on outcomes of patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P355 Acceptability of treatment regimen in inflammatory bowel disease: Results from a prospective nationwide study (ACCEPT2)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P355: A structured care pathway improves quality of care for acute severe ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P355: Diagnostic accuracy and usability of home calprotectin testing
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P355: Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P355: Exceeding treatment expectations in Crohn's disease: transmural healing and a new definition of deep remission
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P355: Motility in small bowel strictures in Crohn's Disease measured with cine-MRI
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P355: Preferences and satisfaction of IBD patients in whom the adalimumab regimen was changed from 40 mg weekly to 80 mg every other week: the ADASCAL study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P355: Prevalence, clinical characteristics and outcomes of CMV colitis in a cohort of 95 patients with ulcerative colitis: A 7-year retrospective analysis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P356 Infectious events in patients with inflammatory bowel disease: The impact of immunomodulators and tumour necrosis factor antagonist therapy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P356: A comparison of innovative strategies to promote engagement with an IBD patient portal
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM